AAAAAA

   
Results: 1-10 |
Results: 10
Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects
Authors: Ecder, T Schrier, RW
Citation: T. Ecder et Rw. Schrier, Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects, J AM S NEPH, 12(1), 2001, pp. 194-200
Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease
Authors: Ecder, T Edelstein, CL Fick-Brosnahan, GM Johnson, AM Chapman, AB Gabow, PA Schrier, RW
Citation: T. Ecder et al., Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease, AM J NEPHR, 21(2), 2001, pp. 98-103
Outcome of living unrelated (commercial) renal transplantation
Authors: Sever, MS Kazancioglu, R Yildiz, A Turkmen, A Ecder, T Kayacan, SM Celik, V Sahin, S Aydin, AE Eldegez, U Ark, E
Citation: Ms. Sever et al., Outcome of living unrelated (commercial) renal transplantation, KIDNEY INT, 60(4), 2001, pp. 1477-1483
Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase
Authors: Knotek, M Rogachev, B Wang, W Ecder, T Melnikov, V Gengaro, PE Esson, M Edelstein, CL Dinarello, CA Schrier, RW
Citation: M. Knotek et al., Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase, KIDNEY INT, 59(6), 2001, pp. 2243-2249
Unifying hypothesis of body fluid volume regulation: Implications for cardiac failure and cirrhosis
Authors: Schrier, RW Ecder, T
Citation: Rw. Schrier et T. Ecder, Unifying hypothesis of body fluid volume regulation: Implications for cardiac failure and cirrhosis, MT SINAI J, 68(6), 2001, pp. 350-361
Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure
Authors: Melnikov, VY Ecder, T Fantuzzi, G Siegmund, B Lucia, MS Dinarello, CA Schrier, RW Edelstein, CL
Citation: Vy. Melnikov et al., Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure, J CLIN INV, 107(9), 2001, pp. 1145-1152
Progress in blood pressure control in autosomal dominant polycystic kidneydisease
Authors: Ecder, T Edelstein, CL Fick-Brosnahan, GM Johnson, AM Duley, IT Gabow, PA Schrier, RW
Citation: T. Ecder et al., Progress in blood pressure control in autosomal dominant polycystic kidneydisease, AM J KIDNEY, 36(2), 2000, pp. 266-271
Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidneydisease
Authors: Ecder, T Chapman, AB Brosnahan, GM Edelstein, CL Johnson, AM Schrier, RW
Citation: T. Ecder et al., Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidneydisease, AM J KIDNEY, 35(3), 2000, pp. 427-432
Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease
Authors: Ecder, T Edelstein, CL Chapman, AB Johnson, AM Tison, L Gill, EA Brosnahan, GM Schrier, RW
Citation: T. Ecder et al., Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease, NEPH DIAL T, 14(5), 1999, pp. 1113-1116
Interaction between cyclosporine A and verapamil, felodipine, and isradipine
Authors: Yildiz, A Sever, MS Turkman, A Ecder, T Turk, S Akkaya, V Ark, E
Citation: A. Yildiz et al., Interaction between cyclosporine A and verapamil, felodipine, and isradipine, NEPHRON, 81(1), 1999, pp. 117-118
Risultati: 1-10 |